TacticScaleWhat Fortive Does & How It Makes Money (FTV)
Updated October 2026 · reflects Fortive's latest reported financials
Maker of industrial test instruments, workplace software, and hospital workflow tools. It earns revenue by selling instruments and equipment, plus software and services such as maintenance, repair, and facility and asset management applications, to industrial, utility, and healthcare customers.
How Fortive makes money
It earns revenue by selling instruments and equipment, plus software and services such as maintenance, repair, and facility and asset management applications, to industrial, utility, and healthcare customers.
What Fortive does
Fortive Corporation, incorporated in 2015 and headquartered in Everett, Washington, sells products, software, and services in the United States, China, and internationally. Its Intelligent Operating Solutions segment is the larger portfolio of brands. It covers instrumentation for measurement, maintenance, repair, and condition monitoring (Fluke), connected worker safety (Industrial Scientific), and software for managing facilities, assets, and compliance (Accruent, Gordian, Intelex, ServiceChannel). Customers include manufacturing, process industries, utilities and power, communications and electronics, and healthcare. The Advanced Healthcare Solutions segment serves hospitals and clinical settings. It offers instrument sterilization (ASP), instrument tracking (Censis), biomedical test tools (Fluke Biomedical), radiation detection and safety monitoring (Landauer), and end-to-end clinical productivity software (Provation). Together, the two segments combine physical instruments with recurring software and service offerings.
Products & services
- Fluke test and measurement tools
- Industrial Scientific gas detection and worker safety
- Accruent, Gordian and ServiceChannel facility and asset software
- Intelex safety and compliance software
- ASP instrument sterilization
- Landauer radiation monitoring
What is Fortive worth?
On an owner-earnings DCF, Fortive's most-likely value is about $73 versus a recent price near $57 (27% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$35) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Fortrea (FTRE) · FormFactor (FORM) · Teleflex (TFX) · Fortinet (FTNT) · Thermo Fisher Scientific (TMO)